Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
MSCI reports Q3 results on October 20 with a notable tension: short sellers have been adding positions at an unusual pace while the borrow market and options signals remain far from stressed, a split that sets up an interesting read-through ahead of a print where the stock has historically moved sharply.
The most striking positioning development is the pace of short rebuilding. Short interest has nearly doubled over the past month, rising 92% to reach 2.6% of the free float. The weekly gain of 41% is equally notable. Even so, the absolute level stays modest for a stock of this quality profile: 2.6% short interest is not a crowded bear thesis, it is a measured, growing one. The borrow market supports that read: availability is effectively unlimited, with 72 million shares available against fewer than 2 million shorted, and the cost to borrow has dropped sharply this week to 0.22%, its lowest level in the 30-day window shown. New shorts face no friction whatsoever getting into the position. Options, meanwhile, are barely defensive. The put/call ratio at 1.06 is slightly below its 20-day average of 1.14, suggesting no unusual demand for downside protection. Taken together, the shorts are building quietly but there is no panic hedging around them.
The Street remains broadly constructive, though targets have been drifting lower ahead of the print. JP Morgan trimmed its target to $685 from $700 just yesterday, maintaining Overweight, and Morgan Stanley cut to $662 from $700 on Tuesday, also staying Overweight. Wells Fargo made a smaller trim to $685 at end of September. The direction is clear: analysts are pulling numbers in without abandoning the bull call. The consensus mean target of $678 still implies roughly 21% upside from the current price of $561, a gap wide enough that even after the recent cuts the Street sees material room to recover. The valuation picture is mixed. The EV/EBITDA multiple at 20x has compressed modestly over the past month, a small relief on an expensive name, while the trailing PE of 25.7x remains elevated. The factor score picture reinforces the quality tilt: MSCI ranks in the 97th percentile on dividend score and 70th on days-to-cover, but only the 19th percentile on EV/EBIT, the value screen that keeps sceptics interested.
The ownership data adds one genuinely interesting data point. T. Rowe Price added 604,800 shares in the quarter to September, bringing its stake to 3.3% of shares. That is a material addition from a conviction-oriented manager and the largest incremental move among the top 15 holders. On the insider side, director Rajat Taneja made an open-market purchase of 1,786 shares at $560 on September 2, a $1 million commitment at nearly the current price, with no 10b5-1 plan attached. CEO Henry Fernandez also bought 1,238 shares in May at $562. Both trades are at prices close to where the stock is today, and neither carries the preplanned-sale caveat that would dilute the signal. No 13D activist is on the register; the activist table is dominated by passive Schedule 13G filers, the largest being BlackRock at 7.6% as last disclosed in February 2025.
The earnings history is the clearest reason for caution around the short build. The last quarterly print, in July, produced an 8.7% one-day drop and the stock was still down 7.3% five days later. The Q1 2026 print in April produced the mirror image, a 7.2% one-day gain. MSCI moves on results. With the stock effectively flat over a month and the short position doubling, the next print on October 20 decides whether the recent bear positioning was well-timed or squeezed out.
The short score has also picked up, jumping from the low 30s to 33.6 over the past week, though it remains a mid-range reading that does not signal an extreme. Wikipedia attention ran at a z-score of 2.1 relative to its 90-day history as of late September, pointing to above-average retail interest at a time when the stock has been going sideways. With six days to the print, what matters most now is whether the subscription-growth trajectory justifies targets that are already coming in from all directions.
See the live data behind this article on ORTEX.
Open MSCI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
